CytomX Therapeutics, Inc. (CTMX) Reports Material Event to SEC
Filing Details CytomX Therapeutics, Inc. (NASDAQ:CTMX) filed a Form 8-K with the Securities and Exchange Commission on July 27, 2026, disclosing a material event. Market Context…
Read more
